News + Filings Holdings
|
Decheng Capital Management III (Cayman), LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
Zentalis Pharmaceuticals, Inc.
| ZNTL | Common | 2,099,583 | 275,000 | 59,229,236,000 | 27,846,408,000 | 18.58 | 3.53 |
Hist
| 06/30/2023 |
ACELYRIN, Inc.
| SLRN | Common | 1,554,417 | 1,554,417 | 32,487,315,000 | 32,487,315,000 | 10.19 | |
Hist
| 06/30/2023 |
10x Genomics, Inc.
| TXG | Common | 359,554 | 0 | 20,077,495,000 | 17,977,000 | 6.30 | |
Hist
| 06/30/2023 |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
| PACB | Common | 1,463,872 | 0 | 19,469,498,000 | 2,517,860,000 | 6.11 | 0.59 |
Hist
| 06/30/2023 |
Arcus Biosciences, Inc.
| RCUS | Common | 869,790 | 0 | 17,665,435,000 | 1,800,465,000 | 5.54 | 1.19 |
Hist
| 06/30/2023 |
ILLUMINA, INC.
| ILMN | Common | 80,859 | 0 | 15,160,254,000 | -3,643,506,000 | 4.76 | |
Hist
| 06/30/2023 |
Phathom Pharmaceuticals, Inc.
| PHAT | Common | 850,000 | 850,000 | 12,172,000,000 | 12,172,000,000 | 3.82 | 1.95 |
Hist
| 06/30/2023 |
ARGENX SE
| ARGX | SPONSORED ADR | 27,429 | 0 | 10,689,904,000 | 470,407,000 | 3.35 | 0.05 |
Hist
| 06/30/2023 |
Horizon Therapeutics Public Ltd Co
| HZNP | Common Stock | 78,900 | 0 | 8,114,865,000 | -496,281,000 | 2.55 | |
Hist
| 06/30/2023 |
Terns Pharmaceuticals, Inc.
| TERN | Common | 714,285 | 0 | 6,249,994,000 | -2,207,140,000 | 1.96 | 1.26 |
Hist
| 06/30/2023 |
Seagen Inc.
| SGEN | COM | 23,014 | 0 | 4,429,274,000 | -230,371,000 | 1.39 | |
Hist
| 06/30/2023 |
Aura Biosciences, Inc.
| AURA | Common | 293,333 | 0 | 3,622,663,000 | 900,533,000 | 1.14 | 0.78 |
Hist
| 06/30/2023 |
Aadi Bioscience, Inc.
| AADI | Common | 526,329 | 0 | 3,600,090,000 | -210,532,000 | 1.13 | 2.15 |
Hist
| 06/30/2023 |
Embarq CORP
| EQ | COM | 4,447,308 | 0 | 3,335,481,000 | 88,946,000 | 1.05 | |
Hist
| 06/30/2023 |
Cue Health Inc.
| HLTH | Common | 8,980,909 | 0 | 3,322,936,000 | -13,022,318,000 | 1.04 | 5.92 |
Hist
| 06/30/2023 |
Mersana Therapeutics, Inc.
| MRSN | Common | 904,268 | 0 | 2,975,042,000 | -741,499,000 | 0.93 | 0.79 |
Hist
| 06/30/2023 |
SCYNEXIS INC
| SCYX | COM NEW | 555,555 | 0 | 1,638,887,000 | -27,778,000 | 0.51 | 1.67 |
Hist
| 06/30/2023 |
Adicet Bio, Inc.
| ACET | Common | 505,668 | -74,332 | 1,228,773,000 | -2,112,027,000 | 0.39 | 1.18 |
Hist
| 06/30/2023 |
Apexigen, Inc.
| APGN | Common | 1,894,551 | 0 | 814,278,000 | -108,368,000 | 0.26 | 7.68 |
Hist
| 06/30/2023 |
GeneDx Holdings Corp.
| SMFR | Common | 103,604 | -3,315,325 | 617,479,000 | -630,430,000 | 0.19 | |
Hist
| 06/30/2023 |
NeuBase Therapeutics, Inc.
| NBSE | Common | 50,000 | -950,000 | 92,500,000 | -92,500,000 | 0.03 | 0.15 |
Hist
| 06/30/2023 |
BeyondSpring Inc.
| BYSI | SHS | 0 | -4,958,143 | 0 | -5,553,120,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Owlet, Inc.
| OWLT | Common | 0 | -898,400 | 0 | -291,441,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Prometheus Biosciences, Inc.
| RXDX | Common | 0 | -150,000 | 0 | -16,098,000,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
AtriCure, Inc.
| ATRC | COMMON | 0 | -46,259 | 0 | -1,917,436,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
|
|
|